CA125 as a predictive marker for optimal interval debulking surgery in advanced ovarian cancer.

Abstract

e15543 Background: Neoadjuvant chemotherapy (NAC) followed by interval debulking surgery (IDS) is an accepted treatment for patients with advanced ovarian cancer. It is unclear, however, whether achieving optimal IDS can be predicted by preoperative analysis using imaging (CT and MRI) or by measuring cancer antigen (CA) 125 levels. The aim of the present… (More)

Topics

Cite this paper

@article{Furukawa2011CA125AA, title={CA125 as a predictive marker for optimal interval debulking surgery in advanced ovarian cancer.}, author={N. Furukawa and Hiroshi Shigetomi and S. Yoshida and Ren Kawaguchi and Seiji Komeda and Yasuhito Tanase and Y. Yamada and H. Kobayashi}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2011}, volume={29 15_suppl}, pages={e15543} }